acetylcysteine has been researched along with Gastric Diseases in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Álvarez, N; Azúa, E; Cabrera, N; Candia, R; Espino, A; Gálvez, C; Glasinovic, E; González, J; González, R; Monrroy, H; Parra-Blanco, A; Rojas, C; Vargas, JI; Vidaurre, J | 1 |
Demirturk, L; Gurbuz, AK; Ozel, AM; Ozturk, R; Yazgan, Y; Yildirim, S | 1 |
Geniram, A; Marini, U; Spotti, D; Visconti, G | 1 |
Barreto, JC; Miller, TA; Smith, GS; Tornwall, MS | 1 |
Filippini, L; Nauer, E | 1 |
Mori, Y; Murakami, S | 1 |
Davenport, HW | 1 |
Lindstedt, G; Ståhl, E; Wigand, G | 1 |
3 trial(s) available for acetylcysteine and Gastric Diseases
Article | Year |
---|---|
Use of N-acetylcysteine plus simethicone to improve mucosal visibility during upper GI endoscopy: a double-blind, randomized controlled trial.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Antifoaming Agents; Double-Blind Method; Endoscopy, Gastrointestinal; Expectorants; Female; Gastric Mucosa; Humans; Male; Middle Aged; Simethicone; Stomach Diseases; Water | 2018 |
Effect of N-acetyl cysteine on Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
Controlled endoscopic study on gastroduodenal safety of acetylcysteine after oral administration.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Bronchitis; Clinical Trials as Topic; Double-Blind Method; Duodenal Diseases; Endoscopy; Female; Humans; Male; Middle Aged; Placebos; Stomach Diseases | 1980 |
5 other study(ies) available for acetylcysteine and Gastric Diseases
Article | Year |
---|---|
Protective action of oral N-acetylcysteine against gastric injury: role of hypertonic sodium.
Topics: Acetylcysteine; Administration, Oral; Animals; Female; Gastric Mucosa; Hypertonic Solutions; Rats; Rats, Sprague-Dawley; Serine; Sodium; Stomach Diseases; Stomach Ulcer | 1993 |
[The treatment of gastric bezoars].
Topics: Acetylcysteine; Antifungal Agents; Bezoars; Bicarbonates; Bromelains; Cellulase; Female; Gastric Lavage; Gastroscopy; Humans; Papain; Sodium; Stomach Diseases | 1975 |
Changes in the structure of rat mucous glycoprotein and prostaglandin cytoprotection.
Topics: Acetylcysteine; Adhesiveness; Animals; Dinoprostone; Ethanol; Gastric Mucosa; Glycoproteins; Male; Mercaptoethanol; Molecular Weight; Prostaglandins E; Rats; Rats, Inbred Strains; Stomach Diseases | 1986 |
Protein-losing gastropathy produced by sulfhydryl reagents.
Topics: Acetylcysteine; Animals; Blood Proteins; Chelating Agents; Chloromercuribenzoates; Dogs; Gastric Fistula; Gastric Juice; Gastric Lavage; Gastric Mucosa; Histamine Release; Indicator Dilution Techniques; Protein-Losing Enteropathies; Secretory Rate; Sodium; Stomach; Stomach Diseases; Sulfhydryl Compounds; Sulfhydryl Reagents | 1971 |
Treatment of gastric mycosis.
Topics: Acetylcysteine; Achlorhydria; Adult; Antifungal Agents; Candidiasis; Female; Gastric Lavage; Gastric Mucosa; Humans; Mycoses; Stomach Diseases | 1969 |